Despite the increasing prevalence of sleep apnoea, little information is available regarding its impact on the peri-operative outcome of patients undergoing posterior lumbar fusion. Using a national database, patients who underwent lumbar fusion between 2006 and 2010 were identified, sub-grouped by diagnosis of sleep apnoea and compared. The impact of sleep apnoea on various outcome measures was assessed by regression analysis. The records of 84 655 patients undergoing posterior lumbar fusion were identified and 7.28% (n = 6163) also had a diagnostic code for sleep apnoea. Compared with patients without sleep apnoea, these patients were older, more frequently female, had a higher comorbidity burden and higher rates of peri-operative complications, post-operative mechanical ventilation, blood product transfusion and intensive care. Patients with sleep apnoea also had longer and more costly periods of hospitalisation.

In the regression analysis, sleep apnoea emerged as an independent risk factor for the development of peri-operative complications (odds ratio (OR) 1.50, confidence interval (CI) 1.38;1.62), blood product transfusions (OR 1.12, CI 1.03;1.23), mechanical ventilation (OR 6.97, CI 5.90;8.23), critical care services (OR 1.86, CI 1.71;2.03), prolonged hospitalisation and increased cost (OR 1.28, CI 1.19;1.37; OR 1.10, CI 1.03;1.18).

Patients with sleep apnoea who undergo posterior lumbar fusion pose significant challenges to clinicians.

Cite this article: Bone Joint J 2014;96-B:242–8.

Increasing numbers of posterior lumbar fusions are being performed. The purpose of this study was to identify trends in demographics, mortality and major complications in patients undergoing primary posterior lumbar fusion. We accessed data collected for the Nationwide Inpatient Sample for each year between 1998 and 2008 and analysed trends in the number of lumbar fusions, mean patient age, comorbidity burden, length of hospital stay, discharge status, major peri-operative complications and mortality. An estimated 1 288 496 primary posterior lumbar fusion operations were performed between 1998 and 2008 in the United States. The total number of procedures, mean patient age and comorbidity burden increased over time. Hospital length of stay decreased, although the in-hospital mortality (adjusted and unadjusted for changes in length of hospital stay) remained stable. However, a significant increase was observed in peri-operative septic, pulmonary and cardiac complications. Although in-hospital mortality rates did not change over time in the setting of increases in mean patient age and comorbidity burden, some major peri-operative complications increased. These trends highlight the need for appropriate peri-operative services to optimise outcomes in an increasingly morbid and older population of patients undergoing lumbar fusion.

We performed a meta-analysis of modern total joint replacement (TJR) to determine the post-operative mortality and the cause of death using different thromboprophylactic regimens as follows: 1) no routine chemothromboprophylaxis (NRC); 2) Potent anticoagulation (PA) (unfractionated or low-molecular-weight heparin, ximelagatran, fondaparinux or rivaroxaban); 3) Potent anticoagulation combined (PAC) with regional anaesthesia and/or pneumatic compression devices (PCDs); 4) Warfarin (W); 5) Warfarin combined (WAC) with regional anaesthesia and/or PCD; and 6) Multimodal (MM) prophylaxis, including regional anaesthesia, PCDs and aspirin in low-risk patients. Cause of death was classified as autopsy proven, clinically certain or unknown. Deaths were grouped into cardiopulmonary excluding pulmonary embolism (PE), PE, bleeding-related, gastrointestinal, central nervous system, and others (miscellaneous). Meta-analysis based on fixed effects or random effects models was used for pooling incidence data.

In all, 70 studies were included (99 441 patients; 373 deaths). The mortality was lowest in the MM (0.2%) and WC (0.2%) groups. The most frequent cause of death was cardiopulmonary (47.9%), followed by PE (25.4%) and bleeding (8.9%). The proportion of deaths due to PE was not significantly affected by the thromboprophylaxis regimen (PA, 35.5%; PAC, 28%; MM, 23.2%; and NRC, 16.3%). Fatal bleeding was higher in groups relying on the use of anticoagulation (W, 33.8%; PA, 9.4%; PAC, 10.8%) but the differences were not statistically significant.

Our study demonstrated that the routine use of PA does not reduce the overall mortality or the proportion of deaths due to PE.

Purpose: To determine mortality and morbidity for bilateral total knee replacment compared to unilateral knee replacement and revision total knee replacement using the National National Hospital Discharge Survey to include large numbers of patients and look at outcomes.

Method: We analyzed nationally representative data to elucidate the demographics, comorbidities, hospital stay, in-hospital complications and mortality of patients undergoing BTKA and compared them with those of patients undergoing UTKA and revision TKA (RTKA). Data in the National Hospital Discharge Survey on hospital discharges with procedure codes for BTKA, UTKA and RTKA between 1990 and 2004 was analyzed. The demographics, comorbidities, in-hospital stay, complications and mortality were studied. We identified 4,169,489 discharges (153,259 BTKAs; 3,677,161 UTKAs; and 339,069 RTKAs).

Results: Patients undergoing BTKA were younger (1.5 years) and had a lower prevalence of comorbidities for hypertension (vs. UTKA), diabetes, lung disease, and coronary artery disease (vs. UTKA and RTKA). The length of hospitalization was 5.8 days for BTKA, 5.28 for UTKA, and 5.41 for RTKA. Despite similar length of hospitalization, the prevalence of procedure related complications was higher for BTKA (14.17%+/−0.76 (SE)) than for UTKA (9.01%+/−0.17) and RTKA (9.84%+/−0.57). In hospital mortality was highest for BTKA patients (BTKA: 0.47%+/−0.15%; UTKA: 0.30%+/−0.03; RTKA: 0.27%+/−0.09).

Conclusion: Despite younger age and lower comorbidity burden, patients undergoing BTKA had an approximately 1.6 times higher rate of procedure related complications and mortality compared to those undergoing UTKA. Outcomes for RTKA patients for most variables were similar to those for UTKA. In a multivariate analysis, BTKA, advanced age and male gender were independent risk factors for complications and mortality following TKA surgery.